By contrast, NPTX2 seems to be downregulated in all symptomatic stages of the disease, suggesting a different pathogenic behaviour of this protein in AD (Galasko et al. 2019; Nilsson et al. 2021; Soldan et al. 2019; Xiao et al. 2017). The gene discussed is NPTX2; the disease is Alzheimer disease.